Tchaikapharma High Quality Medicines AD Share Price

Equities

THQM

BG1100008074

Pharmaceuticals

End-of-day quote Bulgaria S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
17.3 BGN -0.57% Intraday chart for Tchaikapharma High Quality Medicines AD -0.57% +1.76%

Financials

Sales 2022 42.96M 23.53M 1.96B Sales 2023 48.51M 26.57M 2.22B Capitalization 1.51B 827M 68.95B
Net income 2022 2M 1.1M 91.35M Net income 2023 3M 1.64M 137M EV / Sales 2022 31.9 x
Net Debt 2022 11.66M 6.39M 533M Net Debt 2023 11.1M 6.08M 507M EV / Sales 2023 31.3 x
P/E ratio 2022
469 x
P/E ratio 2023
444 x
Employees 191
Yield 2022 *
-
Yield 2023
-
Free-Float 10.13%
More Fundamentals * Assessed data
Dynamic Chart
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tchaikapharma High Quality Medicines AD Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Tchaikapharma High Quality Medicines Ad Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Tchaikapharma High Quality Medicines Ad Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day-0.57%
1 week-0.57%
3 months+1.76%
6 months+1.76%
Current year+1.76%
More quotes
1 week
17.30
Extreme 17.3
17.40
1 month
17.10
Extreme 17.1
17.40
Current year
16.90
Extreme 16.9
17.40
1 year
15.70
Extreme 15.701
17.40
3 years
12.56
Extreme 12.5608
17.40
5 years
8.52
Extreme 8.5162
17.40
10 years
2.38
Extreme 2.3795
17.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 27/12/27
Members of the board TitleAgeSince
Chief Executive Officer - 27/12/27
More insiders
Date Price Change Volume
26/24/26 17.3 -0.57% 50
25/24/25 17.4 +0.58% 50
23/24/23 17.3 -0.57% 60

End-of-day quote Bulgaria S.E., April 26, 2024

More quotes
Tchaikapharma High Quality Medicines AD is a Bulgaria-based company engaged in the generic pharmaceuticals industry. The Company specializes in manufacture of both generic and in-licensed medicines destined for alimentary tract and metabolism and antiinfectitives for systemic use, as well as cardiovascular, musculoskeletal, nervous and other systems. It also offers solutions for injection and vitamins and nutritional supplements.
More about the company